KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Cash (2016 - 2025)

Historic Change in Cash for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $9.0 million.

  • Staar Surgical's Change in Cash rose 13136.27% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year decrease of 6677.15%. This contributed to the annual value of -$38.9 million for FY2024, which is 14026.49% down from last year.
  • Staar Surgical's Change in Cash amounted to $9.0 million in Q3 2025, which was up 13136.27% from -$6.0 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Change in Cash ranged from a high of $55.6 million in Q4 2023 and a low of -$73.2 million during Q3 2022
  • Moreover, its 5-year median value for Change in Cash was $6.9 million (2023), whereas its average is $2.4 million.
  • Per our database at Business Quant, Staar Surgical's Change in Cash crashed by 133589.6% in 2022 and then soared by 107505.73% in 2024.
  • Over the past 5 years, Staar Surgical's Change in Cash (Quarter) stood at $3.5 million in 2021, then plummeted by 1335.9% to -$42.8 million in 2022, then surged by 230.04% to $55.6 million in 2023, then crashed by 135.69% to -$19.8 million in 2024, then soared by 145.47% to $9.0 million in 2025.
  • Its Change in Cash stands at $9.0 million for Q3 2025, versus -$6.0 million for Q2 2025 and $29.0 million for Q1 2025.